Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for
market hendrychova
Your search for
Markéta Hendrychova
retrieved no results
Consumption of osteoanabolic drugs and strontium ranelate in the treatment of osteoporosis in the Czech Republic in 2005-2011.
Acta Pol Pharm. 2014 Mar-Apr;71(2):329-35.
Acta Pol Pharm. 2014.
PMID: 25272654
Free article.
The objective was to analyze trends in consumption of osteoanabolic and dual drugs in the treatment of osteoporosis since their introduction onto the market in CZ (2005-2011). The prescription-based database of the General Health insurance Company of the Czech Republic tha …
The objective was to analyze trends in consumption of osteoanabolic and dual drugs in the treatment of osteoporosis since their introduction …
Promising 2,6,9-Trisubstituted Purine Derivatives for Anticancer Compounds: Synthesis, 3D-QSAR, and Preliminary Biological Assays.
O Salas C, Zarate AM, Kryštof V, Mella J, Faundez M, Brea J, Loza MI, Brito I, Hendrychová D, Jorda R, Cabrera AR, Tapia RA, Espinosa-Bustos C.
O Salas C, et al.
Int J Mol Sci. 2019 Dec 25;21(1):161. doi: 10.3390/ijms21010161.
Int J Mol Sci. 2019.
PMID: 31881717
Free PMC article.
Compound 7h was found to be an effective potential agent when compared with a currently marketed drug, cisplatin, in four out of the seven cancer cell lines tested. ...
Compound 7h was found to be an effective potential agent when compared with a currently marketed drug, cisplatin, in four out of the …
Item in Clipboard
Cite
Cite